Koninklijke Philips (PHG) Income from Continuing Operations (2009 - 2026)
Koninklijke Philips (PHG) recorded quarterly Income from Continuing Operations of 273954482.12 in Q1 2026, up 27.91% quarter-over-quarter from 214184006.7 in Q4 2025, and up 98.81% on a YoY basis from 137796861.58 in Q1 2025.
Koninklijke Philips (PHG) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Koninklijke Philips' Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 273954482.12 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 98.81% year-over-year to 273954482.12; the TTM figure through Mar 2026 stood at 1518066824.66 (up 11459.7% YoY), while the FY2025 annual figure was 1047639163.23, up 216.71% from the prior year.
- Income from Continuing Operations was 273954482.12 for Q1 2026 at Koninklijke Philips, up from 214184006.7 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 1077964463.87 in Q2 2024 to a low of 1732215298.56 in Q3 2022.
- Historically, Income from Continuing Operations has averaged 259283448.44 across 5 years, with a median of 294322826.69 in 2024.
- The sharpest annual moves came in 2022 and 2024: Income from Continuing Operations sank 729.82% in 2022, then soared 285.03% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 108146220.72 in 2022, then tumbled by 495.94% to 644488005.48 in 2023, then tumbled by 40.93% to 908306090.14 in 2024, then surged by 123.58% to 214184006.7 in 2025, then grew by 27.91% to 273954482.12 in 2026.
- The last three Income from Continuing Operations figures came in at 273954482.12 (Q1 2026), 214184006.7 (Q4 2025), and 423197943.07 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 238.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 273.95 Mn |
| Dec 31, 2025 | 214.18 Mn |
| Sep 30, 2025 | 423.20 Mn |
| Jun 30, 2025 | 606.73 Mn |
| Mar 31, 2025 | 137.80 Mn |
| Dec 31, 2024 | -908.31 Mn |
| Sep 30, 2024 | -294.32 Mn |
| Jun 30, 2024 | 1.08 Bn |
| Mar 31, 2024 | -1.09 Bn |
| Dec 31, 2023 | -644.49 Mn |
| Sep 30, 2023 | -435.44 Mn |
| Jun 30, 2023 | -582.57 Mn |
| Mar 31, 2023 | -743.83 Mn |
| Dec 31, 2022 | -108.15 Mn |
| Sep 30, 2022 | -1.73 Bn |
| Jun 30, 2022 | -280.64 Mn |
| Mar 31, 2022 | -320.99 Mn |
| Dec 31, 2021 | 145.28 Mn |
| Sep 30, 2021 | 334.92 Mn |
| Jun 30, 2021 | 44.56 Mn |